Literature DB >> 28114586

Cytokine Profiles of Tear Fluid From Patients With Pediatric Lacrimal Duct Obstruction.

Nozomi Matsumura1, Satoshi Goto2, Eiichi Uchio3, Kyoko Nakajima4, Takeshi Fujita1, Kazuaki Kadonosono5.   

Abstract

Purpose: This study evaluated the cytokine levels in unilateral tear samples from both sides in patients with pediatric lacrimal duct obstruction.
Methods: Fifteen cases of unilateral lacrimal duct obstruction (mean, 26.9 ± 28.7 months old) were enrolled in this study. Tear samples were collected separately from the obstructed side and the intact side in each case before surgery, which was performed under general anesthesia or sedation. The levels of IL-2, IL-4, IL-6, IL-10, TNF, IFN-γ, and IL-17A then were measured in each tear sample. A receiver operating characteristic (ROC) curve was constructed for the IL-6 levels in the tears. We also measured the postoperative tear fluid levels of IL-6 in those cases from which tear fluid samples could be collected after the surgery.
Results: Only the IL-6 concentration was significantly higher on the lacrimal duct-obstructed sides, compared to the control sides (P < 0.001). An ROC curve analysis for the IL-6 levels in tears showed a high value for discriminating the lacrimal duct-obstructed side from the control side (area under the ROC curve [AUC], 0.99; 95% confidence interval [CI], 0.968-1). Significant decrease of the tear fluid IL-6 levels was observed in the seven cases from which tear fluid samples also could be collected after the surgery (P = 0.016). Conclusions: The IL-6 level in tear fluid was significantly higher on the sides with lacrimal duct obstruction, compared to the control sides, and could be a biomarker for pediatric lacrimal duct obstruction.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28114586     DOI: 10.1167/iovs.16-20717

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  4 in total

1.  Transcanalicular endoscopic primary dacryoplasty for congenital nasolacrimal duct obstruction.

Authors:  Nozomi Matsumura; Toru Suzuki; Satoshi Goto; Takeshi Fujita; Shin Yamane; Maiko Maruyama-Inoue; Kazuaki Kadonosono
Journal:  Eye (Lond)       Date:  2019-02-19       Impact factor: 3.775

2.  The role of IL-6-174 G/C polymorphism and intraocular IL-6 levels in the pathogenesis of ocular diseases: a systematic review and meta-analysis.

Authors:  Zulvikar Syambani Ulhaq; Gita Vita Soraya; Lely Retno Wulandari
Journal:  Sci Rep       Date:  2020-10-15       Impact factor: 4.379

3.  Detection & analysis of inflammatory cytokines in tears of patients with lacrimal duct obstruction.

Authors:  Dan Wang; Nan Xiang; Wei Kun Hu; Ban Luo; Xiang Tian Xiao; Yin Zhao; Bin Li; Rong Liu
Journal:  Indian J Med Res       Date:  2021-06       Impact factor: 5.274

4.  Rebamipide promotes lacrimal duct epithelial cell survival via protecting barrier function.

Authors:  Hiroshi Tanaka; Tomomichi Nakayama; Michiko Tsukamoto; Akihide Watanabe; Takahiro Nakamura; Norihiko Yokoi; Chie Sotozono; Shigeru Kinoshita
Journal:  Sci Rep       Date:  2020-02-03       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.